Clinical trials
Recruiting Thrombocythemia, Essential trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2015 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 9 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 4 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| University Hospital, Angers | 2 |
| University Hospital, Brest | 2 |
| Damora Therapeutics | 1 |
| Eilean Therapeutics AU Pty Ltd | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Fox Chase Cancer Center | 1 |
| Hangzhou GluBio Pharmaceutical Co., Ltd. | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 32 |
| Primary Myelofibrosis | 25 |
| Polycythemia Vera | 21 |
| Myeloproliferative Disorders | 17 |
| Myelodysplastic Syndromes | 8 |
| Leukemia, Myeloid, Acute | 6 |
| Myelodysplastic-Myeloproliferative Diseases | 5 |
| Leukemia | 4 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Multiple Myeloma | 4 |
Trials
Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.